ENTITY
Medy Tox Inc

Medy Tox Inc (086900 KS)

52
Analysis
Health CareSouth Korea
Medy-Tox Inc. is a biopharmaceutical company. The Company researches, develops and manufactures biopharmaceutical products using clostridium botulinum which is a microorganism toxin.
more
Refresh
bullishSK Bioscience
26 Apr 2021 04:56

KOSPI200 Index Rebalance Preview: Review Period Almost Complete; Short Selling Commences in a Week

There could be up to 6 inclusions and 8 exclusions at the KOSPI200 index review in June. The inclusions could outperform the exclusions as short...

Logo
336 Views
Share
bearishLG Chem Ltd
15 Apr 2021 04:15

LGChem/SKI Deal - Another Korea Discount Worry? Follow the Female Lead

IP protection is a big worry for Korean firms - has the 2 precedent cases in Korea in 2021 lower the value of IP from the view of international...

Logo
222 Views
Share
bullishMedy Tox Inc
28 Jul 2020 08:11

Medytox Rights Offer: Terms & Situations

Medytox, which used to be one of the bluechip names on KOSDAQ, announces a ₩130bil rights offering.It offers a total of 0.97M shares, which...

Logo
337 Views
Share
bearishHugel Inc
29 Jun 2020 18:11

Hugel Placement: A 5.2% Block Deal Sale

After the market close today, it was reported that BK Medical Group’s Chairman Dr. Kim Byung-Gun and Dr. BK Corp will sell their 5.2% stake...

Logo
288 Views
Share
28 Mar 2019 21:42

Smartkarma’s Week That Was in JP/​​​​​​​​KR: Semiconductor Warnings, Exit of Chairman Cho, & 청년수당

In the past week, there were earnings warnings from three major players in the global semiconductor sector, including Samsung Electronics (005930...

Logo
578 Views
Share
x